Physician profile
Patrick J Brennan
NPI 1104876945
$2,208.15
in general payments reported to CMS, 2019-2025
20 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,408 · 2020: $90.64 · 2021: $44.30 · 2022: $170 · 2023: $343 · 2024: $44.56 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,525.52 | 2019-2023 | Da Vinci Surgical System |
| Bard Access Systems, INC. | $86.04 | 2019 | |
| Janssen Biotech, INC. | $81.77 | 2023 | Stelara |
| Integra Lifesciences Corporation | $74.20 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Csl Behring | $45.86 | 2019-2023 | Kcentra |
| Covidien LP | $44.14 | 2019 | |
| Octapharma USA, INC. | $40.34 | 2024-2025 | Fibryga |
| Ethicon US, LLC | $37.43 | 2020-2021 | |
| Kls-Martin L.P. | $34.61 | 2022-2023 | |
| Tela Bio, INC. | $34.30 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $27.40 | 2022 | |
| Boston Scientific Corporation | $26.68 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.90 | 2023 | Entyvio |
| Astrazeneca Pharmaceuticals LP | $20.67 | 2024 | Andexxa |
| Abbvie INC. | $20.41 | 2023 | Rinvoq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $19.29 | 2023 | On-Q* Pump and Accessories |
| Teleflex LLC | $17.47 | 2023 | Quikclot |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.60 | 2022 | |
| Becton, Dickinson and Company | $16.23 | 2023 | Rotarexs 6 F X 135 Cm |
| W. L. Gore & Associates, INC. | $15.29 | 2025 | Gore Synecor Biomaterial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Brennan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.